Pirfenidone gel in patients with localized scleroderma: a phase II study

Overview of attention for article published in Arthritis Research & Therapy, December 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

So far, Altmetric has seen 9 X posts from 7 X users, with an upper bound of 31,277 followers.

RT @RheumNow: Uncontrolled trial of Perfenidone (antifibrotic) gel in 12 pts w/ localized scleroderma shows major skin benefits https://t.…

RT @RheumNow: Uncontrolled trial of Perfenidone (antifibrotic) gel in 12 pts w/ localized scleroderma shows major skin benefits https://t.…

RT @RheumNow: Uncontrolled trial of Perfenidone (antifibrotic) gel in 12 pts w/ localized scleroderma shows major skin benefits https://t.…

RT @RheumNow: Uncontrolled trial of Perfenidone (antifibrotic) gel in 12 pts w/ localized scleroderma shows major skin benefits https://t.…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.